References
- 1. Bernardin, G., Pradier, C., Tiger, F., et al. Blood pressure and arterial lactate level are early indicators of shortterm survival in human septic shock// Intensive Care Medicine, 1996; 22:17-25
- 2. Berry, M. N. The liver and lactic acidosis// Proc. Royal Society of Medicine, 1967; 60: 1260-2
- 3. Bersten, A.D., Soni, N. Oh’s intensive care manual. -6th ed. - Philadelphia: Butterworth Heinemann Elsvier 2009. - Pp. 145.-147
- 4. Broder, G., Weil, M.H. Excess lactate: an index of reversibility of shock in human patients// Science, 1964; 143: 1457-9
- 5. Cady, L. D., Weil, M. W., Afifi, A. A., et al. Quantitation of severity of critical illness with special reference to blood lactate//Critical Care Medicine, 1973; 1:75-80
- 6. Chertoff, J., Chisum, M., Garcia, B., Lascano, J. Lactate kinetics in sepsis and septic shock: a review of the literature and rationale for further research// Journal of Intensive Care, 2015; 3:39
- 7. Dellinger, R. P., Levy, M. M., Rhodes, A., et al. Surviving Sepsis Campaign: International Guidelines for Management of Severe Sepsis and Septic Shock: 2012// CriticalCare Medicine, 2013; 41: 580-595
- 8. Gillet, Y., Bertrand, I., Vanhems, P., et al. Association between Staphylococcus aureus strains carrying gene for Panton-Valentine leukocidin and highly lethal necrotising pneumonia in young immunocompetent patients//Lancet, 2002; 359: 753 - 759
- 9. Gunnerson, K.J., Saul, M., He, S. et al. Lactate versus nonlactate metabolic acidosis: a retrospective outcome evaluation of critically ill patients//Critical Care Medicine, 2006; 10(1): R22
- 10. Gutierrez, F., Masia, M., Rodriguez, J. C., et al. M. Epidemiology of community-acquired pneumonia in adult patients at the dawn of the 21st century: a prospective study on the Mediterranean coast of Spain. Clinical Microbiology and Infectology, 2005; 11: 788-800
- 11. Gutierrez, G., Wulf, M. E. Lactic acidosis in sepsis: another commentary// Critical Care Medicine, 2005; 33: 2420-2
- 12. Heper, Y., Akal, E. H., Mistik, R., et al. Evaluation of serum C-reactive protein, procalcitonin, tumor necrosis factor alpha, and interleukin-10 levels as diagnostic and prognostic parameters in patients with communityacquired sepsis, severe sepsis, and septic shock// European Journal ofClinical Microbiology and Infectious Diseases, 2006; 25:481-491
- 13. Jansen, T. C., Bommel, J., Schoonderbeek, J.,et al. Early Lactate-Guided Therapy in Intensive Care Unit Patients// American Journal of Respiratory and Critical Care Medicine, 2010; 182: 752-761
- 14. Jat, K. N., Jhamb, U., Gupta, V. K. Serum lactate levels as the predictorof outcome in pediatric septic shock// Indian Journalof Critical Care Medicine, 2011; 15: 102-7
- 15. Knaus, W. A., Draper, E. A., Wagner, D. P., et al. APACHE II: a severity of disease classification system// Critical Care Medicine, 1985; 13: 818-29
- 16. Loke, Y. K., Kwok, C. S., Niruban, A., Myint, P. K. Value of severity scales in predicting mortality from community-acquired pneumonia: systematic rewiev and meta-analysis// Thorax, 2010; 65: 884-890
- 17. Lozano, R., Naghavi, N., Foreman, K.,et al. Global and regional mortality from 235causesof death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010// Lancet, 2012; 380 (9859): 2095-128
- 18. Members of the American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference Committee (1992). Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis// Critical Care Medicine, 1992; 20: 864-874
- 19. Mikkelsen, M. E., Miltiades, A. N., Gaieski, D. F., et al. Serum lactate is associated with mortality in severe sepsis independent of organ failure and shock// Critical Care Medicine, 2009; 37: 1670-1677
- 20. Moine, P., Vercken, J. B., Chevret, S., et al. Severe Community-Acquired Pneumonia: Etiology, Epidemiology, Prognosis Factors//Chest, 1994; 105:1487-1495
- 21. Neil, A. M., Martin, I. R., Weir, R. et al. Community acquired pneumonia: aetiology and usefullness of severity criteria on admission// Thorax, 1996; 51: 1010-6
- 22. Odom, S. R. Llactate clearance as a predictor of mortality//The Journal of Tauma and Acute Care Surgery, 2014; 77: 183-4
- 23. Peake, L. S., Denaley, A., Bailey, M., et al (ARISE Investigators and the ANZICS Clinical Trials Group). Goal-Directed Resuscitation for Patients with Early Septic Shock//New England Journal of Medicine, 2014; 371: 1496-506
- 24. Peake, S. L., et al. Goal-directed resuscitation for patients with early septic shock. N Engl J Med, 2014; 371(16): 1496-506
- 25. Richards, G.,Levy, H., Laterre, P. F., Feldman, C., Woodward, B., Bates, B. M., Qualy, R. L. CURB-65, PSI, and APACHE II to assess mortality risk in patients with severe sepsis and community acquired pneumonia in PROWESS//Journal of Intensive Care Medicine, 2011; 26(1): 34-40
- 26. Rivers, E., Nguyen, B., Havstad, S. et al. Early goaldirected therapy in treatment of severe sepsis and septic shock//New England Journal of Medicine, 2001; 345:1368-77
- 27. Shapiro, N., Howell, M. D., Talmor, D., et al. Serum lactate as a predictor of mortality in emergency department patients with infection// Annals of Emergency Medicine, 2005; 45(5):524-8
- 28. Sligl, W. I., Marrie, J. T. Severe Community- Acquired Pneumonia// Critical Care Clinics, 2013; 29: 563-601
- 29. Smith, I., Kumar, P., Molly, S., et al. Base excess and lactate as prognostic indicators for patients admitted to intensive care// Intensive Care Medicine, 2001; 27:74-83
- 30. Suistomaa, M., Ruokonen, E., Kari, A., et al. Timepattern of lactate and lactate to pyruvate ratio in the first 24 hours of intensive care emergency admissions// Shock, 2000; 14(1): 8-12
- 31. Wiemken, L. T., Peyrani, P., Ramirez, J. A. Global Changes in the Epidemiology of Community- Acquired Pneumonia// Semin of Respiratory Critical Care Medicine, 2012; 33: 213-219